Showing results (261-270 of 818) with videos related to
Sort By:
Pageof 82
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|January 24, 2015
Appetite control and energy balance: impact of exerciseJ E Blundell, C Gibbons, P Caudwell, et al.Frontiers in Oncology|September 12, 2019
Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and DocetaxelAshley M Hopkins, Andrew Rowland, Ross A McKinnon, et al.European Journal of Cancer & Clinical Oncology|March 1, 1982
Retinoic acid binding proteins and steroid receptor levels in human breast cancerR G Mehta, T E Kute, M Hopkins, et al.Biology of Reproduction|December 1, 1984
Source of F series prostaglandins during the early postpartum period in cattleL A Guilbault, W W Thatcher, M Drost, et al.The Quarterly Journal of Medicine|July 1, 1993
Rhabdomyolysis and acute renal failure in unsuspected malignant hyperpyrexiaA P Burns, P M Hopkins, G Hall, et al.Antisense & Nucleic Acid Drug Development|November 18, 2000
The influence of arm length asymmetry and base substitution on the activity of the 10-23 DNA enzymeM J Cairns, T M Hopkins, C Witherington, et al.Analytical Biochemistry|April 29, 2004
Characterization of major histocompatibility complex-associated peptides from a small volume of whole bloodLeann M Hopkins, Michael Schall, Joseph F Leykam, et al.Pigment Cell & Melanoma Research|February 14, 2019
Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial dataAshley M Hopkins, Madele Van Dyk, Andrew Rowland, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2019
Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical TrialsMichael J Sorich, Andrew Rowland, Christos S Karapetis, et al.Cellular Oncology (Dordrecht, Netherlands)|November 15, 2017
Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen speciesCathy E Richards, Sri H Vellanki, Yvonne E Smith, et al.Pageof 82